Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/07/2010CA2592605C Method for stabilizing anti-dementia drug
12/07/2010CA2462637C Timed, sustained release multi-particulate dosage forms of propranolol
12/07/2010CA2461659C Modified release dosage forms
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2453263C Pharmaceutical compositions containing terbinafine and use thereof
12/07/2010CA2432456C Remineralising dental adhesive film
12/07/2010CA2425199C Formulation of substituted benzimidazoles
12/07/2010CA2406261C Antiinflammatory-containing plaster
12/07/2010CA2404767C Bile secretion promoting composition containing a 15-keto prostaglandin
12/07/2010CA2386339C Dip coating compositions containing cellulose ethers
12/07/2010CA2381802C Synergistic combination of roflumilast and salmeterol
12/07/2010CA2299522C Diluting and disintegrating composition, method for obtaining same and use thereof
12/07/2010CA2201368C Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies
12/07/2010CA2153653C Growth differentiation factor-9
12/05/2010CA2705657A1 Delivery of functional compounds
12/05/2010CA2705629A1 Novel preparation of an enteric release system
12/03/2010CA2698632A1 Microneedle array using porous substrate and production method thereof
12/02/2010WO2010138918A1 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010WO2010138884A2 Compositions, methods & systems for respiratory delivery of two or more active agents
12/02/2010WO2010138868A2 Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems
12/02/2010WO2010138862A2 Compositions for respiratory delivery of active agents and associated methods and systems
12/02/2010WO2010138823A1 Compositions and methods for inactivation of pathogens at genital tract surfaces
12/02/2010WO2010138770A2 Methods for administration and formulations for the treatment of regional adipose tissue
12/02/2010WO2010138661A1 Nanoparticulate anticancer compositions and methods for making the same
12/02/2010WO2010138660A1 Anticancer pharmaceutical formulation
12/02/2010WO2010138539A2 Reduction of flake-like aggregation in nanoparticulate active agent compositions
12/02/2010WO2010138519A2 Use of adsorbent carbon microspheres for the treatment of pruritus
12/02/2010WO2010138469A2 Two-piece bandage system, swab and cotton product
12/02/2010WO2010138441A1 Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen
12/02/2010WO2010138439A1 Multiparticulate controlled-release selective serotonin reuptake inhibitor formulations
12/02/2010WO2010138099A1 Dermal medicament delivery system causing an exothermic reaction
12/02/2010WO2010138074A1 Hyaluronic acid based delivery systems
12/02/2010WO2010138064A1 Aqueous film coating composition
12/02/2010WO2010137888A2 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same
12/02/2010WO2010137855A2 Multi-layer tablet comprising effervescent layer
12/02/2010WO2010137716A1 Orally disintegrating tablet which contains precipitated calcium carbonate as active ingredient
12/02/2010WO2010137699A1 Patch material
12/02/2010WO2010137696A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
12/02/2010WO2010137681A1 Prophylactic or therapeutic agent for retinal diseases comprising tranilast, method for prevention or treatment of retinal diseases, and tranilast or pharmaceutically acceptable salt thereof and use thereof
12/02/2010WO2010137613A1 Solid preparation having improved storage stability
12/02/2010WO2010137570A1 Anti-viral agent or an anti-cancer agent
12/02/2010WO2010137335A1 TURN-OVER-ACCELERATING COMPOSITION CONTAINING α-LIPOIC ACID NANOPARTICLES
12/02/2010WO2010137122A1 Collagen production enhancer
12/02/2010WO2010136952A2 Self-microemulsifying mitotane composition
12/02/2010WO2010136947A1 Liposome based diepitope constructs
12/02/2010WO2010136872A2 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
12/02/2010WO2010136847A1 Coated metformin with pioglitazone solution
12/02/2010WO2010136839A1 Use of deferoxamine and related compounds in targeted delivery forms to treat an inflammatory bowel disease
12/02/2010WO2010136740A1 Method for preparing hollow particles, and uses thereof
12/02/2010WO2010136739A2 Controlled-release floating pharmaceutical compositions
12/02/2010WO2010136676A1 Functional amphiphilic molecule or macromolecule formulations with multiple compartments
12/02/2010WO2010136589A1 Treatment of tissue adhesion
12/02/2010WO2010136588A2 Dry powder fibrin sealant
12/02/2010WO2010136285A1 Composition
12/02/2010WO2010136221A1 Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics
12/02/2010WO2010136219A1 Enteric coating
12/02/2010WO2010136193A1 Pharmaceutical composition comprising tamsulosin
12/02/2010WO2010136149A1 Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide
12/02/2010WO2010119346A3 Herbal compositions and methods for enhancing vital energy and athletic performance
12/02/2010WO2010117733A3 Methods and apparatus for dispensing medicaments into a punctal plug
12/02/2010WO2010117346A3 Stable pharmaceutical compositions with high bioavailability
12/02/2010WO2010117091A3 Antimycotic pharmaceutical composition
12/02/2010WO2010109212A3 Carrier comprising a vitamin e derivative
12/02/2010WO2010103539A3 Sustained release oral formulation of vinpocetine
12/02/2010WO2010087947A3 Transdermal delivery of diclofenac, carbamazepine and benzydamine
12/02/2010WO2010080970A3 Oral enteric antidepressant formulation
12/02/2010WO2010059253A3 Methods and compositions for localized agent delivery
12/02/2010WO2010057295A9 Homeopathic composition comprising hypericum perforatum extract and essential oils for the treatment of neuropathic pain
12/02/2010WO2010043950A3 Propafenone extended release composition
12/02/2010WO2010001325A3 Methods, compositions and systems for local delivery of drugs
12/02/2010WO2009129470A3 Methods for treating herpes virus infections
12/02/2010WO2009120699A3 Antimicrobials having polyquarternary ammoniums and alcohol-bearing amidoamines and methods for their use
12/02/2010WO2000045847A8 Novel mucosal delivery system
12/02/2010US20100305696 Hybrid soft tissue implants from progenitor cells and biomaterials
12/02/2010US20100305522 Fluid medication delivery device
12/02/2010US20100305521 Fluid medication delivery device
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305218 Nanoemulsions
12/02/2010US20100305208 Gastric retention controlled drug delivery system
12/02/2010US20100305179 Oral sustained-release tablet
12/02/2010US20100305178 Pharmaceutical Composition
12/02/2010US20100304484 Use of Alginate Matrices to Control Cell Growth
12/02/2010US20100303923 Endotoxin adsorbent for the prevention and treatment of autoimmune diseases
12/02/2010US20100303922 Method for the preparation of biocompatible polymeric nanoparticles for drug delivery and nanoparticles prepared thereby
12/02/2010US20100303921 Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan
12/02/2010US20100303920 Aqueous Film Coating Composition / 841
12/02/2010US20100303919 Pharmaceutical compositions comprising fluvastatin
12/02/2010US20100303918 Compositions and methods for treating asthma and other lung disorders
12/02/2010US20100303917 Compositions and methods for treating cystic fibrosis
12/02/2010US20100303916 Enhanced drug delivery with orientable particles
12/02/2010US20100303915 Therapeutic opthalmic emulsions
12/02/2010US20100303914 Self-Gelling Alginate Systems and Uses Thereof
12/02/2010US20100303913 Method for Nanoencapsulation
12/02/2010US20100303912 Nanocell Drug Delivery System
12/02/2010US20100303911 Hydrogel systems
12/02/2010US20100303910 Topical skin care compositions
12/02/2010US20100303909 Preparation for treating heart disease used in cell therapy
12/02/2010US20100303908 Pharmaceutical composition comprising desloratadine
12/02/2010US20100303907 Standardized plant extract, process for obtaining the same and uses thereof
12/02/2010US20100303906 Solid dosage forms of valsartan and amlodipine and method of making same
1 ... 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 ... 2991